Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
The Journal of rheumatology 2011-01
Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series.
Related Questions
How would you approach management of a patient with sJIA that was previously well controlled on tocilizumab but is now having ongoing joint disease activity?
Patient has had intolerance to methotrexate and leflunomide in the past.
New comment
by at Northwestern University ( April 28, 2025)
Agree with above. Another option if that fails is a JAK-i (tofacitinib, ruxolitinib) +/- IL-1 inhibitor.
Read more (1 Answer available)
23750
×
To continue please login or register
Register
or
Sign in